Ravoxertinib Uses, Dosage, Side Effects and more
Ravoxertinib is under investigation in clinical trial NCT01875705 (A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors).
| Trade Name | Ravoxertinib |
| Generic | Ravoxertinib |
| Ravoxertinib Other Names | Ravoxertinib |
| Type | |
| Formula | C21H18ClFN6O2 |
| Weight | Average: 440.86 Monoisotopic: 440.1163797 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
